Website stats for Acastipharma - acastipharma.com
Language: English
Keywords: Grace Therapeutics, Biotechnology, Treatments, Serious Diseases, News Alerts, Cookie Policies
Layout: Homepage with navigation bar, clear banner, and sections for information and cookie policies.
ColorStyle: The website uses a color scheme with shades of blue and white, creating a professional and trustworthy atmosphere.
Overview: Grace Therapeutics is a biotechnology company that develops innovative treatments for serious diseases. The website homepage welcomes visitors with a clear and professional design, featuring a large banner with text about their mission and a call to action to sign up for news alerts. The site also includes a navigation bar at the top and a section at the bottom about their cookie policies. The overall layout is clean and organized, with a focus on providing information about their company and its mission.
acastipharma.com was registered 1 decade 6 years ago. It has a alexa rank of #4,525,068 in the world. It is a domain having .com extension. It is estimated worth of $ 240.00 and have a daily income of around $ 1.00. As no active threats were reported recently, acastipharma.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 194 |
| Daily Pageviews: | 388 |
Estimated Valuation
| Income Per Day: | $ 1.00 |
| Estimated Worth: | $ 240.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | 4,550 |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 4,525,068 |
| PageSpeed Score: | 79 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
174.129.30.187
Hosted Country:
US
Location Latitude:
39.0395Location Longitude:
-77.4918Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | 31.22% |
| Referral Traffic: | 12.35% |
| Search Traffic: | 48.98% |
| Social Traffic: | 7.45% |
| Mail Traffic: | 0% |
| Display Traffic: | 0% |
Search Engine Results For acastipharma.com
Acasti Pharma Inc. (ACST)
Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of...
Acasti Pharma, Inc. (ACST) Stock Price, News, Quote ...
Find the latest Acasti Pharma, Inc. (ACST) stock quote, history, news and other vital information to help you with your stock trading and investing.
Acasti Pharma, Inc. (ACST) Company Profile & Facts - Yahoo ...
Description. Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of...
ACST - Acasti Pharma Inc. • BioPharmCatalyst
LAVAL, Québec, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ:ACST, TSXV:ACST), announces the voting results for the matters listed...
Acasti Pharma Stock Loses a Wall Street Supporter | Nasdaq
Sep 01, 2020 · The week couldn’t have gotten off to a worse start for investors of Acasti Pharma (ACST). Shares cratered by a massive 65% in Monday’s trading following the...
Acasti Pharma Inc. (NASDAQ:ACST) Forecast to gain 380.95% ...
Sep 29, 2020 · Acasti Pharma Inc. (NASDAQ:ACST) has a beta value of 0 and has seen 2,977,302 shares traded in the last trading session. The company, currently valued at $19.3...
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing ...
Jun 19, 2020 · About Acasti Pharma. Acasti is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the...
Acasti Pharma Reports Topline Triglyceride Results from ...
Aug 31, 2020 · Acasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe Hypertriglyceridemia CaPre achieved a 30.4%...
Acasti Pharma Inc (ACST) Quote | Morningstar
Acasti Pharma Inc is a biopharmaceutical innovator advancing a cardiovascular drug, CaPre (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition...
Acasti Pharma (Class A) - ACST - Stock Price & News | The ...
Real time Acasti Pharma (Class A) (ACST) stock price quote, stock graph, news & analysis.
Acasti Pharma Inc. Stock Price (ACST) | Barron's
Oct 23, 2020 · View today's stock price, news and analysis for Acasti Pharma Inc. (ACST). Barron's also provides information on historical stock ratings, target prices, …
ACST Stock Forecast, Price & News (Acasti Pharma)
5 analysts have issued 12-month price objectives for Acasti Pharma's shares. Their forecasts range from $0.50 to $7.00. On average, they anticipate Acasti Pharma's stock price...
ACST: Acasti Pharma Inc - Full Company Report - Zacks.com
Sep 30, 2020 · Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid...
ACST Stock Price Quote & News - Acasti Pharma | Robinhood
View the real-time ACST price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read...
Acasti Pharma, Inc (ACST) Stock Analysis Buy and Sell ...
Acasti Pharma, Inc. SCoRE: 43 . Learn about the SCoRE. PRICE ACTION $0.1896. LAST PRICE - 06:33pm. ACST is trading at yesterday's close of $0.1896. Right now ACST is $0.0054...
Acasti Pharma Inc (ACST-X) Quote - The Globe and Mail
Acasti Pharma Inc is a biopharmaceutical innovator advancing a cardiovascular drug, CaPre (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition...
Acasti Pharma, Inc. - ACST - Stock Price Today - Zacks
Oct 29, 2020 · Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid...
ACASTI PHARMA INC. (NASDAQ:ACST) Files An 8-K Other Events ...
Sep 29, 2020 · Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical...
What Makes Acasti (ACST) a New Buy Stock | Nasdaq
Aug 14, 2020 · Acasti Pharma (ACST) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in …
ACST:NASDAQ CM Stock Quote - Acasti Pharma Inc - Bloomberg ...
Stock analysis for Acasti Pharma Inc (ACST:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | 1 |
| H3 Headings: | 3 | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 4 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Websites Hosted on Same IP (i.e. 174.129.30.187)
Bristow Group Inc. (VTOL)
Bristow provides safe, reliable and efficient helicopter services for offshore oil and gas transportation, SAR and government and civil organizations.
1,136,615 
$ 1,200.00
Brunswick Corporation (BC)
Brunswick Corporation, a world-class leader in the marine industry, turns innovation into reality via renowned marine brands.
335,184 $ 27,540.00
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Mon, 24 Jun 2019 11:03:36 GMT
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Vary: Accept-Encoding
Content-Encoding: gzip
Content-Length: 3896
Content-Type: text/html; charset=UTF-8
Domain Information
| Domain Registrar: |
GoDaddy.com, LLC
|
|---|---|
| Registration Date: | 2008-08-01 1 decade 6 years 3 months ago |
| Last Modified: | 2015-05-19 9 years 6 months 6 days ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns77.domaincontrol.com | |
97.74.108.49 | United States |
| ns78.domaincontrol.com | |
173.201.76.49 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| acastipharma.com | A | 591 |
IP: 174.129.30.187 |
| acastipharma.com | NS | 3600 |
Target: ns78.domaincontrol.com |
| acastipharma.com | NS | 3600 |
Target: ns77.domaincontrol.com |
| acastipharma.com | SOA | 3600 |
MNAME: ns77.domaincontrol.com RNAME: dns.jomax.net Serial: 2019050600 Refresh: 28800 Retry: 7200 Expire: 604800 |
| acastipharma.com | MX | 3600 |
Priority: 5 Target: mail-gateway.acastipharma.com |
| acastipharma.com | TXT | 3600 |
TXT: google-site-verification=BIrGcd6A0i09lbL wKxEyPYacha4CRApqmmWEOJvQKa0 |
| acastipharma.com | TXT | 3600 |
TXT: v=spf1 a mx include:mail-gateway-1.neptunebiotech.co m ~all |
| acastipharma.com | TXT | 3600 |
TXT: v=verifydomain MS=5983861 |
PC Thumbnail
Mobile Thumbnail
Top Organic Keyword
| 1. | acasti |
| 2. | acasti pharma |
| 3. | acasti pharma sherbrooke |
| 4. | capre acasti trademarkia |
| 5. | a phase 3 study of capre in lowering very high triglycerides (trilogy 1) (trilogy 1) |
Top Paid Keyword
| Not Applicable |
Full WHOIS Lookup
Registry Domain ID:
1511372729_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.godaddy.com
Registrar URL:
http://www.godaddy.com
Updated Date:
2015-05-19T13:44:23Z
Creation Date:
2008-07-31T18:52:17Z
Registry Expiry Date:
2020-07-31T18:52:17Z
Registrar: GoDaddy.com, LLC
Registrar
IANA ID: 146
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
480-624-2505
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientRenewProhibited
https://icann.org/epp#clientRenewProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS77.DOMAINCONTROL.COM
Name Server:
NS78.DOMAINCONTROL.COM
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2019-06-24T11:03:34Z
Similarly Ranked Websites
Startseite | Oligo
Modulare Leuchtensysteme und elegante Einzelleuchten von Oligo bietet perfekte Lichtlösungen in LED- und Halogen-Technik für den Einsatz in privaten und öffentlichen Bereichen.
4,525,201 $ 240.00
Online Shop für Spielzeug, Mobiltelefone, Elektronik & Spiele -...
Bei xmen.ch finden Sie über 65'000 Produkte: Fernseher, Spielzeuge, Notebooks, Laptops, Mobiltelefone und Haushaltsgeräte zu günstigen Preisen - Schnelle Lieferung in die ganze...
4,525,242 $ 240.00